M&A Deal Summary |
|
|---|---|
| Date | 2011-07-01 |
| Target | UAB SORPO |
| Sector | Life Science |
| Buyer(s) | MediCap Holding AS |
| Sellers(s) | Thermo Fisher Scientific |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2008 |
| Sector | Healthcare Services |
| Employees | 200 |
MediCap Holding AS is a healthcare service provider. MediCap Holding AS was established in 2008 and is headquartered in Tartu, Estonia.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: Lithuania M&A | 1 of 1 |
| Year: 2011 M&A | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 1956 |
| Sector | Test/Measurement Equipment |
| Employees | 122,000 |
| Revenue | 42.9B USD (2024) |
Thermo Scientific provides analytical instruments, laboratory equipment, software, services, consumables and reagents for better workflow solutions spanning sample preparation, sample analysis, and data interpretation. Thermo Fisher Scientific was founded in 1956 and is based in Waltham, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 8 |
| Sector: Life Science M&A | 3 of 4 |
| Type: Divestiture M&A Deals | 3 of 7 |
| Country: Lithuania M&A | 1 of 1 |
| Year: 2011 M&A | 4 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-05-19 |
Phadia AB
Uppsala, Sweden Phadia AB,a provider in in-vitro allergy diagnostics and the European leader in autoimmunity diagnostics. It has a global footprint, distributing directly in 21 territories and enjoying further reach through a broad international network of distributors. The company is headquartered in Uppsala, Sweden, and employs over 1,100 people worldwide. |
Buy | $2.4B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-07-18 |
Trek Diagnostic Systems
Cleveland, Ohio, United States Trek develops and markets diagnostic testing products used to detect and identify infectious organisms and determine their susceptibility to various types, combinations and concentrations of antimicrobial agents. Trek markets its products primarily to the clinical, veterinary and pharmaceutical industries. |
Buy | - |
